insights_auto
Por que TNDM subiu 2,74%?
Saiba maischevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
US$ 17,26
arrow_upward
+2,74%(+0,46) 1D
20 de nov., 15:05:05 -5 GMT · USD
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para TNDM…
Abrir
US$ 16,61
Alta
US$ 17,86
Baixa
US$ 16,51
Valor de mercado
1,20 bi
Volume médio
2,58 mi
Volume
1,03 mi
Alto — 52 sem
US$ 29,65
Baixo — 52 sem
US$ 12,26
LPA
-US$ 0,72
Beta
1,59
Ações em circulação
69,79 mi
Nº de funcionários
2 mil
Abrir
US$ 16,61
Alta
US$ 17,86
Baixa
US$ 16,51
Valor de mercado
1,20 bi
Volume médio
2,58 mi
Volume
1,03 mi
Alto — 52 sem
US$ 29,65
Baixo — 52 sem
US$ 12,26
LPA
-US$ 0,72
Beta
1,59
Ações em circulação
69,79 mi
Nº de funcionários
2 mil
Notícias
De fontes da web e parceiros de notícias
Seeking Alpha
·
há 2 dias
Tandem upgraded, Insulet downgraded at Stifel on market for tubeless insulin pumps
Yahoo Finance
·
há 2 dias
Insulet downgraded, Tandem Diabetes upgraded: Wall Street's top analyst calls
Investing.com
·
há 2 dias
Stifel upgrades Tandem Diabetes stock rating on product pipeline
Perfil
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Sobre Tandem Diabetes Care Inc
CEOJohn Sheridan
Funcionários2,5 mil
Data de fundaçãojan. 2006
Sede-
SetorHealth Care
Setor-